Dr. O'Regan Discusses BELLE-3 Study in Breast Cancer



Dr. O'Regan Discusses BELLE-3 Study in Breast Cancer

Other buzz videos

Bruce Johnson Talks About The New Orbis Flying Hospital N330AU

Bruce Johnson Talks About The New Orbis Flying Hospital N330AU

ER-signaling in HER2-postive Breast Cancer - Dr. Ruth O'Regan

ER-signaling in HER2-postive Breast Cancer - Dr. Ruth O'Regan

Immunotherapy in Breast Cancer

Immunotherapy in Breast Cancer

Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and Promises

Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and Promises

Extended Adjuvant Therapy for HER2+ Early Breast Cancer

Extended Adjuvant Therapy for HER2+ Early Breast Cancer

Adjuvant Treatment, HER2 Positive & Targeted Therapies

Adjuvant Treatment, HER2 Positive & Targeted Therapies

MD vs MD/PhD vs PhD: Steve Lee, Ph.D. (2014)

MD vs MD/PhD vs PhD: Steve Lee, Ph.D. (2014)

Sandra Swain, Washington Cancer Institute, Washington, United States

Sandra Swain, Washington Cancer Institute, Washington, United States

Systemic Treatment for Newly Diagnosed FL

Systemic Treatment for Newly Diagnosed FL

Crizotinib for ALK-Rearranged NSCLC

Crizotinib for ALK-Rearranged NSCLC

HER2 Status in Colorectal Cancer

HER2 Status in Colorectal Cancer

Cancer and Its Effects On Bones

Cancer and Its Effects On Bones

Adam Brufsky, MD - University of Pittsburgh Medical Center

Adam Brufsky, MD - University of Pittsburgh Medical Center

Dr. William Gradishar on Updates in NCCN Breast Cancer Guidelines

Dr. William Gradishar on Updates in NCCN Breast Cancer Guidelines

Survivor Story: Linnea Olson

Survivor Story: Linnea Olson

First in-human trials of rovalpituzumab for SCLC

First in-human trials of rovalpituzumab for SCLC

Dr. Lynch on Targeting EGFR Mutation Subtypes in Lung Cancer

Dr. Lynch on Targeting EGFR Mutation Subtypes in Lung Cancer

CDK4/6 Inhibitors in Hormone Receptor-Driven MBC

CDK4/6 Inhibitors in Hormone Receptor-Driven MBC

Dr. Brawer on the Significance of the Prolaris Genetic Test for Prostate Cancer

Dr. Brawer on the Significance of the Prolaris Genetic Test for Prostate Cancer

Dr. Slovin on Approaches of Immunotherapy in Prostate Cancer

Dr. Slovin on Approaches of Immunotherapy in Prostate Cancer